The reason for any potential protective effect of SCT on the severity of DR remains ambiguous, however the observation concurs to some extent with a previous report.[15] In that study, after adjustment for diabetes duration, age, insulin use, and gender, the differences in the prevalence of microvascular complications were no longer observed. The gene discussed is INS; the disease is diabetes mellitus.